The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Bioderm sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Bioderm Inc, United States Revenue

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Bioderm is a medical equipment company that manufactures designs and markets hydrocolloid products. The company offers hydrocolloid products for urinary management, infection control, securement and skin protection. Its products include cathgrip, bioplus+, freederm, men’s liberty, safe n’ dry, and penile clamp, among others. Bioderm’s cathgrip is a catheter securement system, safe n’ dry is a male external catheter for institutional and hospital use and men’s liberty is a male external catheter designed for community dwelling men. The company supplies its products in the application of infection control, urinary management and skin protection. Bioderm headquartered in Largo, Florida, the US. Key subsidiaries of Bioderm include Argentum Medical.

The key metrics of Bioderm related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Bioderm is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Bioderm.

For a detailed understanding of the performance of Bioderm, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.